Who is Martin Shkreli?
Who is the man behind the 5000% price hike for the HIV drug Daraprim?
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Who is Martin Shkreli?
At 32-years old, the hedge fund trader is the Chief Executive of Turing Pharmaceuticals, a start-up based in New York.
Having bought rights to the potentially life-saving drug Daraprim, Shkreli raised its price by over 5000% from $13.50 to $750 per pill.
There was twitter reaction from the likes of actress Ruby Rose and Democrat candidate hopeful, Hillary Clinton:
The decision earned him some unenviable headlines, including 'Meet the most despised man in the world' (Mail Online) and 'The most hated CEO in America' (Financial Post).
It has also been revealed that Shkreli once raised the price of kidney medication by almost 2000% in 2011.
Shkreli has since said that the cost of the HIV drug will be lowered.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments